TrialThe oncologist2020

Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.

Naoki Niikura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.